Betting on FDA Approvals Sparks Ethical Outcry
Treating drug development like a sports book introduces financial incentives that could compromise scientific integrity.
July 22, 2026
Follow us
latest articles
Discover the newest research about AI innovations in 🧪 Drug Discovery.
Anthropic Targets DeepMind in Biopharma Talent War
The battle for AI supremacy has moved from chatbots to wet labs, and Anthropic is spending heavily to challenge Google’s dominance in drug discovery.
July 20, 2026
Bristol Myers Squibb Builds Custom Nvidia Supercomputer
Drug discovery is no longer just a biology problem; it is a massive infrastructure war.
July 20, 2026
Can AI replace animal testing in five years?
The UK is betting £75 million that algorithms can replace animals in drug safety trials, but the regulatory hurdles remain immense.
July 18, 2026
AI Drug Discovery Targets the Factory Floor
A new joint venture is shifting AI’s role from designing molecules to actually building them at scale.
July 17, 2026
Chai Discovery Hits Three Billion Dollar Valuation
A massive new funding round for an AI drug startup shows that Big Pharma is outsourcing its most critical early-stage molecular design.
July 14, 2026
Turning Failed Clinical Trials Into AI Models
Biotech companies are finding a second life for failed drug data, but recycling bad trials into predictive algorithms carries hidden risks.
July 12, 2026
AI agent runs biomedical research tasks autonomously
A new AI agent named Biomni can design and run its own lab experiments, shifting the bottleneck of medical discovery from human labor to machine execution.
July 10, 2026
Pharma Regulatory AI Draws Ninety-Five Million Dollars
A massive influx of capital into clinical trial automation signals that the next high-value AI frontier is boring paperwork.
July 8, 2026
Can AI fix the drug development bottleneck?
A new UK regulatory initiative is putting AI to the test to solve the pharmaceutical industry’s most expensive problem: high failure rates.
July 8, 2026